282 related articles for article (PubMed ID: 12384193)
1. In the dark: the reporting of blinding status in randomized controlled trials.
Montori VM; Bhandari M; Devereaux PJ; Manns BJ; Ghali WA; Guyatt GH
J Clin Epidemiol; 2002 Aug; 55(8):787-90. PubMed ID: 12384193
[TBL] [Abstract][Full Text] [Related]
2. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
Haahr MT; Hróbjartsson A
Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
[TBL] [Abstract][Full Text] [Related]
3. The reporting of blinding in orthodontic randomized controlled trials: where do we stand?
Abdulraheem S; Bondemark L
Eur J Orthod; 2019 Jan; 41(1):54-58. PubMed ID: 29697755
[TBL] [Abstract][Full Text] [Related]
4. Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials.
Devereaux PJ; Manns BJ; Ghali WA; Quan H; Lacchetti C; Montori VM; Bhandari M; Guyatt GH
JAMA; 2001 Apr; 285(15):2000-3. PubMed ID: 11308438
[TBL] [Abstract][Full Text] [Related]
5. An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods.
Devereaux PJ; Choi PT; El-Dika S; Bhandari M; Montori VM; Schünemann HJ; Garg AX; Busse JW; Heels-Ansdell D; Ghali WA; Manns BJ; Guyatt GH
J Clin Epidemiol; 2004 Dec; 57(12):1232-6. PubMed ID: 15617948
[TBL] [Abstract][Full Text] [Related]
6. Definitions of blinding in randomised controlled trials of interventions published in high-impact anaesthesiology journals: a methodological study and survey of authors.
Penić A; Begić D; Balajić K; Kowalski M; Marušić A; Puljak L
BMJ Open; 2020 Apr; 10(4):e035168. PubMed ID: 32284390
[TBL] [Abstract][Full Text] [Related]
7. The blind leading the blind: use and misuse of blinding in randomized controlled trials.
Miller LE; Stewart ME
Contemp Clin Trials; 2011 Mar; 32(2):240-3. PubMed ID: 21070890
[TBL] [Abstract][Full Text] [Related]
8. Deliberate ignorance: a systematic review of blinding in nursing clinical trials.
Polit DF; Gillespie BM; Griffin R
Nurs Res; 2011; 60(1):9-16. PubMed ID: 21127453
[TBL] [Abstract][Full Text] [Related]
9. The quality of reporting of orthopaedic randomized trials with use of a checklist for nonpharmacological therapies.
Chan S; Bhandari M
J Bone Joint Surg Am; 2007 Sep; 89(9):1970-8. PubMed ID: 17768194
[TBL] [Abstract][Full Text] [Related]
10. The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement.
Mills EJ; Wu P; Gagnier J; Devereaux PJ
Contemp Clin Trials; 2005 Aug; 26(4):480-7. PubMed ID: 16054580
[TBL] [Abstract][Full Text] [Related]
11. Specific instructions for estimating unclearly reported blinding status in randomized trials were reliable and valid.
Akl EA; Sun X; Busse JW; Johnston BC; Briel M; Mulla S; You JJ; Bassler D; Lamontagne F; Vera C; Alshurafa M; Katsios CM; Heels-Ansdell D; Zhou Q; Mills E; Guyatt GH
J Clin Epidemiol; 2012 Mar; 65(3):262-7. PubMed ID: 22200346
[TBL] [Abstract][Full Text] [Related]
12. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.
Fergusson D; Glass KC; Waring D; Shapiro S
BMJ; 2004 Feb; 328(7437):432. PubMed ID: 14761905
[TBL] [Abstract][Full Text] [Related]
13. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
Hróbjartsson A; Forfang E; Haahr MT; Als-Nielsen B; Brorson S
Int J Epidemiol; 2007 Jun; 36(3):654-63. PubMed ID: 17440024
[TBL] [Abstract][Full Text] [Related]
14. Reporting on blinding in trial protocols and corresponding publications was often inadequate but rarely contradictory.
Hróbjartsson A; Pildal J; Chan AW; Haahr MT; Altman DG; Gøtzsche PC
J Clin Epidemiol; 2009 Sep; 62(9):967-73. PubMed ID: 19635403
[TBL] [Abstract][Full Text] [Related]
15. Reporting of outcomes in orthopaedic randomized trials: does blinding of outcome assessors matter?
Poolman RW; Struijs PA; Krips R; Sierevelt IN; Marti RK; Farrokhyar F; Bhandari M
J Bone Joint Surg Am; 2007 Mar; 89(3):550-8. PubMed ID: 17332104
[TBL] [Abstract][Full Text] [Related]
16. Blinding in randomized clinical trials: imposed impartiality.
Hróbjartsson A; Boutron I
Clin Pharmacol Ther; 2011 Nov; 90(5):732-6. PubMed ID: 21993424
[TBL] [Abstract][Full Text] [Related]
17. Blinding in Surgical Randomized Clinical Trials in 2015.
Speich B
Ann Surg; 2017 Jul; 266(1):21-22. PubMed ID: 28350566
[TBL] [Abstract][Full Text] [Related]
18. Blinding terminology used in reports of randomized controlled trials involving dogs and cats.
Giuffrida MA; Agnello KA; Brown DC
J Am Vet Med Assoc; 2012 Nov; 241(9):1221-6. PubMed ID: 23078571
[TBL] [Abstract][Full Text] [Related]
19. Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review.
Boutron I; Estellat C; Guittet L; Dechartres A; Sackett DL; Hróbjartsson A; Ravaud P
PLoS Med; 2006 Oct; 3(10):e425. PubMed ID: 17076559
[TBL] [Abstract][Full Text] [Related]
20. Evidence-based recommendations for blinding in surgical trials.
Probst P; Zaschke S; Heger P; Harnoss JC; Hüttner FJ; Mihaljevic AL; Knebel P; Diener MK
Langenbecks Arch Surg; 2019 May; 404(3):273-284. PubMed ID: 30824993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
